Eye Movement Desensitization and ReprocessingNCT06878807
Exploring the Role of Working Memory Saturation in Eye Movement Desensitization and Reprocessing (EMDR) Using the Eye Blink Conditioning Paradigm
A study testing eye movement and TMT-B in people with Eye Movement Desensitization and Reprocessing, run by Hospital Clinic of Barcelona at 1 site in Spain.
Trial summary
Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Eye Movement Desensitization and Reprocessing
- What is being tested?
- eye movement and TMT-B
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 112 participants
- Where
- 1 siteSpain
- Study dates
- 1 Apr 2022to 1 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age between 18 and 65 years
- Provide informed consent
Who cannot join
- Prior exposure to EMDR therapy or eye movement (EM) experiments
- Positive diagnosis of PTSD or other Axis I disorders as determined by the Mini-International Neuropsychiatric Interview (MINI)
- Hearing or visual impairments
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Eye Movements and the Extinction Procedure in Eyeblink Conditioning: A Possible Mechanism of Action for Eye Movement Desensitization and Reprocessing
Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. During EMDR therapy, patients focus on recalling traumatic events while simultaneously engaging with an external stimulus. Specifically, patients undergo lateral eye movements. This process is believed to reduce the vividness and emotional intensity of traumatic memories by addressing and desensitizing their cognitive, emotional, and physical components. Despite its proven efficacy in treating PTSD, the precise mechanisms underlying these therapeutic effects remain not fully understood.
Several hypotheses have been proposed to explain the efficacy of EMDR. Among them, the working memory hypothesis is particularly influential and is supported by a substantial body of research. This hypothesis suggests that aversive memories and fear, when recalled, occupy limited memory resources. Therefore, performing a task, such as eye movements, during the recall of the traumatic experience would result in a competition for limited memory resources, leading to a decrease in the vividness and emotional intensity of the traumatic memory. Consequently, the dual task inherent in EMDR is thought to facilitate a rapid elimination of the emotional responses triggered by the traumatic memory, allowing patients to alleviate the physical and psychological distress associated with the trauma.
Read more
Measuring the effects of an EM intervention through a standardized protocol could clarify the conditions under which the intervention is most effective and elucidate the potential mechanisms of EMDR. In this context, the Eye Blink Conditioning (EBC) task, a well-established and standardized conditioning paradigm, seems relevant for testing the working memory hypothesis.
In the EBC task, eyelid closure is measured in response to a corneal air puff, which acts as the unconditioned stimulus. The unconditioned stimulus is paired with a neutral stimulus, a tone, which becomes a conditioned stimulus by eliciting a conditioned response similar to that produced by the unconditioned stimulus. After the conditioning phase, participants undergo the extinction phase. In this phase, the conditioned stimulus is presented without the unconditioned stimulus for many trials, and the main objective is to measure how many trials it takes for the participants to eliminate the previous associative learning between the aversive stimulus (air puff) and the conditioned stimulus (tone).
This study aimed to explore whether the effectiveness of a straightforward eye movement intervention in accelerating extinction is influenced by the working memory hypothesis. The hypothesis is that the enhancement of extinction learning is dependent on working memory saturation. Understanding the role of working memory saturation in the effectiveness of eye movements during extinction learning could provide critical insights into the working memory hypothesis as a potential key mechanism underlying the efficacy of EMDR therapy.
- Being tested
- eye movement, TMT-B
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
eye movementBehavioural
Participants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration.
TMT-BBehavioural
Participants performed the Trail Making Test B (TMT-B).
| Study group | Role | What they receive |
|---|---|---|
| Eye Movement Intervention | Experimental | Participants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration Receives: Behavioral: eye movement |
| TMT-B | Active comparator | Participants performed the Trail Making Test B (TMT-B). Receives: Behavioral: TMT-B |
| Control group | No intervention | Participants engaged in no additional task. These subjects were told to focus their gaze on a wall in front of them. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Extinction Learning Differences
Assesses the number of conditioned responses (CR) during the initial block of the extinction phase.
Measured: Baseline
Secondary outcomes (4)
Latency of Eyeblink Conditioned Response (CR) During the Eye Blink Conditioning Task
Latency assesses the time of onset of the CR following the conditioned stimulus (CS). Data will be reported as the mean CR onset time per block.
Measured: Baseline
Intensity of Eyelid Closure During the Eye Blink Conditioning Task
Intensity assesses the peak amplitude of the CR during conditioning trials. Data will be reported as the mean CR peak amplitude per block.
Measured: Baseline
Trauma History (Childhood Trauma Questionnaire)
- Childhood Trauma Questionnaire (CTQ): Assesses childhood traumatic exposure. Higher scores indicate greater traumatic exposure.
Measured: Baseline
Trauma History (Life Events Checklist-5)
- Life Events Checklist for DSM-5 (LEC-5): Evaluates exposure to 15 different types of traumatic experiences. Responses indicate whether the participant has experienced each event (Yes/No).
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Mar 2025
- Study start1 Apr 2022
- Primary completion1 Dec 2024
- Study completion1 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Eye Movement Desensitization and ReprocessingStudies of the same condition, open and under way.
- More trials run by Hospital Clinic of BarcelonaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 112 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Clinic of Barcelona
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hugo López-Pelayo, Hospital Clinic of Barcelona
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06878807
- Sponsor's protocol ID
- HCB/2021/0283
- Status last verified
- Sep 2025
- First submitted
- 6 Feb 2025
- Last updated
- 16 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Eye Movements and the Extinction Procedure in Eyeblink Conditioning: A Possible Mechanism of Action for Eye Movement Desensitization and Reprocessing
- ClinicalTrials.gov ID
- NCT06878807
- Acronym / sponsor ID
- HCB/2021/0283
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 112 participants (actual)
- Lead sponsor
- Hospital Clinic of BarcelonaUniversity, hospital or other
- Study start
- 1 Apr 2022 (actual)
- Primary completion
- 1 Dec 2024 (actual)
- Study completion
- 1 Apr 2025 (actual)
- First posted
- 17 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. During EMDR therapy, patients focus on recalling traumatic events while simultaneously engaging with an external stimulus. Specifically, patients undergo lateral eye movements. This process is believed to reduce the vividness and emotional intensity of traumatic memories by addressing and desensitizing their cognitive, emotional, and physical components. Despite its proven efficacy in treating PTSD, the precise mechanisms underlying these therapeutic effects remain not fully understood.
Several hypotheses have been proposed to explain the efficacy of EMDR. Among them, the working memory hypothesis is particularly influential and is supported by a substantial body of research. This hypothesis suggests that aversive memories and fear, when recalled, occupy limited memory resources. Therefore, performing a task, such as eye movements, during the recall of the traumatic experience would result in a competition for limited memory resources, leading to a decrease in the vividness and emotional intensity of the traumatic memory. Consequently, the dual task inherent in EMDR is thought to facilitate a rapid elimination of the emotional responses triggered by the traumatic memory, allowing patients to alleviate the physical and psychological distress associated with the trauma.
Measuring the effects of an EM intervention through a standardized protocol could clarify the conditions under which the intervention is most effective and elucidate the potential mechanisms of EMDR. In this context, the Eye Blink Conditioning (EBC) task, a well-established and standardized conditioning paradigm, seems relevant for testing the working memory hypothesis.
In the EBC task, eyelid closure is measured in response to a corneal air puff, which acts as the unconditioned stimulus. The unconditioned stimulus is paired with a neutral stimulus, a tone, which becomes a conditioned stimulus by eliciting a conditioned response similar to that produced by the unconditioned stimulus. After the conditioning phase, participants undergo the extinction phase. In this phase, the conditioned stimulus is presented without the unconditioned stimulus for many trials, and the main objective is to measure how many trials it takes for the participants to eliminate the previous associative learning between the aversive stimulus (air puff) and the conditioned stimulus (tone).
This study aimed to explore whether the effectiveness of a straightforward eye movement intervention in accelerating extinction is influenced by the working memory hypothesis. The hypothesis is that the enhancement of extinction learning is dependent on working memory saturation. Understanding the role of working memory saturation in the effectiveness of eye movements during extinction learning could provide critical insights into the working memory hypothesis as a potential key mechanism underlying the efficacy of EMDR therapy.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Eye Movement Intervention | Experimental | Behavioral: eye movementParticipants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration |
| TMT-B | Active comparator | Behavioral: TMT-BParticipants performed the Trail Making Test B (TMT-B). |
| Control group | No intervention | –Participants engaged in no additional task. These subjects were told to focus their gaze on a wall in front of them. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age between 18 and 65 years
- Provide informed consent
Key exclusion criteria (3 listed)
- Prior exposure to EMDR therapy or eye movement (EM) experiments
- Positive diagnosis of PTSD or other Axis I disorders as determined by the Mini-International Neuropsychiatric Interview (MINI)
- Hearing or visual impairments
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| eye movementParticipants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration. | Behavioural | Eye Movement Intervention |
| TMT-BParticipants performed the Trail Making Test B (TMT-B). | Behavioural | TMT-B |
Primary outcome
Extinction Learning Differences
Time frame: Baseline
Assesses the number of conditioned responses (CR) during the initial block of the extinction phase.
4 secondary outcomes
Latency of Eyeblink Conditioned Response (CR) During the Eye Blink Conditioning Task
Time frame: Baseline
Intensity of Eyelid Closure During the Eye Blink Conditioning Task
Time frame: Baseline
Trauma History (Childhood Trauma Questionnaire)
Time frame: Baseline
Trauma History (Life Events Checklist-5)
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Eye Movement Desensitization and Reprocessing
Recruiting
Trauma-Focused Group Therapy for Adults With Trauma-Related Symptoms in Primary Care
Psychological Trauma, Stress Disorders, Post-Traumatic; Mental Disorders
Not yet recruiting
Intermittent Theta-Burst Stimulation (iTBS) as an add-on to Eye Movement Desensitization and Reprocessing (EMDR) in the Treatment of Post-traumatic Stress Disorder (PTSD)
PTSD - Post Traumatic Stress Disorder
Recruiting
Efficacy of an EMDR App for PTSD and SUD
Posttraumatic Stress Disorder (PTSD), Substance Use Disorders
Recruiting
EMDR Treatment in PTSD Following Cardiac Events
Posttraumatic Stress Disorder, Myocardial Infarction
Recruiting
Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.
Cancer, Psychological Distress
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing eye movement and TMT-B in people with Eye Movement Desensitization and Reprocessing, run by Hospital Clinic of Barcelona at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Extinction Learning Differences (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2025.